Source Citation
Kessler DS, MacNeill SJ, Tallon D, et al. Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR). BMJ. 2018;363:k4218. https://pubmed.ncbi.nlm.nih.gov/30381374
Clinical Impact Ratings
GIM/FP/GP: 
Mental Health:
References
- 1 Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163:1905-17. [PMID:
17074942 ] Google Scholar - 2 Archer J, Bower P, Gilbody S, et al. Collaborative care for depression and anxiety problems. Cochrane Database Syst Rev. 2012;10:CD006525. [PMID:
23076925 ] Google Scholar
Author, Article and Disclosure Information
Affiliations:
Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA (G.E.S.)
This article was published at Annals.org on 5 February 2019.
Submit a Comment
Contributors must reveal any conflict of interest. Comments are moderated. Please see our information for authorsregarding comments on an Annals publication.
*All comments submitted after October 1, 2021 and selected for publication will be published online only.